Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

Elsevier Launches Mendeley Data to Manage Entire Lifecycle of Research Data

LONDON, April 4, 2018 /PRNewswire/ — Elsevier, the information analytics business specializing in science and health, has launched Mendeley Data, a new, cloud-based platform designed to help universities and researchers manage, share and showcase their research data. With Mendeley Data, researchers can safely record and share research data while improving its reuse via publication, while universities can showcase institutional... Read more

Introduction of the epMotion® 5075 NGS solution for automated library preparation

Hamburg, March 2018 The Next Generation Sequencing (NGS) library preparation process is labor-intensive, requiring experience and attention to detail over hours. Eppendorf is introducing a complete package of epMotion 5075 automated liquid handling workstation with all required accessories, a broad range of vendor specific pre-developed & qualified methods, advantageous consumables and related service products that... Read more

SnapGene and VectorBuilder Partner to Streamline DNA Cloning

April 4, 2018 Biologists can now use SnapGene software to order plasmids directly through VectorBuilder.Chicago, IL – April 4 GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from VectorBuilder through GSL Biotech’s “SnapGene” software. SnapGene was created to meet the everyday needs of... Read more

PerkinElmer Prices Offering of Euro-Denominated Senior Notes

April 4, 2018 at 4:15 PM EDT PDF Version WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of €300 million aggregate principal amount of 0.600% Senior Notes due 2021 at an issue price of 99.950% of the principal... Read more

Dr. David Sinclair Joins Zymo Research Corp.’s Scientific Advisory Board

One of the most important thought leaders in the aging field Dr. David A. Sinclair, an anti-aging specialist, joins Zymo Research’s Scientific Advisory Board. IRVINE, Calif., April 3, 2018 /PRNewswire/ — The Zymo Research Corp. Board of Directors has announced the appointment of David A. Sinclair, Ph.D., O.A., Professor, Principal Investigator and Co-Director of the Paul F. Glenn Labs... Read more

New development in the field of Liquid Handling: Highly viscous substances such as collagen are now pipettable

Hamburg, March 2018 Handling of volumes in the mL range of highly viscous liquids such as 99 % glycerol, detergents or collagen in the laboratory and for analytical purposes has proven difficult, requiring the use of suboptimal tools such as spoons. These requirements cause tremendous delays to analysis and mixing procedures. As such, the precise... Read more

Rigaku Analytical Devices Announces Narcotics-Focused Handheld Raman Analyzer

New Progeny ResQ FLX analyzer integrates latest drug identification technology to keep law enforcement safe while battling opioid epidemic Wilmington, Massachusetts, April 3, 2018 – Rigaku Analytical Devices, a leading pioneer of handheld and portable spectroscopic analyzers, announces the release of the Rigaku Progeny ResQ FLX, handheld Raman analyzer, specifically designed for narcotics identification. Based off... Read more

Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts

New State-of-the-Art Facility Will Support Continued Growth and Innovation MILFORD, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Following recent approval by its Board of Directors, Waters Corporation (NYSE: WAT) announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as... Read more